Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EROSION IV
NCT07567625Recruiting
- Sponsor
- Harbin Medical University
- Start
- Jul 2026
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Randomised, open-label trial in acute myocardial infarction (AMI) (2 arms), sponsored by Harbin Medical University. Primary endpoint: Target Lesion Failure at 30 months. Started Jul 2026; status: recruiting.
02
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT07567625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07567625.